Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Endocyte ( ECYT) is a biopharmaceutical company. Endocyte is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is trading up 7.6% to $8.20 in recent trading.

Today's Range: $7.85-$8.57

52-Week Range: $3.02-$14.80

Volume: 5.1 million

Three-Month Average Volume: 970,978

>>7 Hot Stocks on Traders' Radars

From a technical perspective, ECYT is continuing to move higher today after the stock just gapped up huge yesterday from under $4 to $7.50 on monster volume. This move today is pushing the stock back above its 200-day moving average of $7.99 with heavy volume.

Traders should now look for long biased trades as long as ECYT is trending above its 200-day, and if it can manage to close near its daily highs today. If we continue to see ECYT trending above its 200-day, then this stock could easily tag its December high of $11.11 soon.

That said, any high-volume drop back below its 200-day, and below its gap-day high low of $7.23 could put this stock in danger to fill some of that massive gap to the downside.

If you liked this article you might like

3 Stocks Improving Performance Of The Computer Software & Services Industry

Top Image Systems (TISA) Prices Secondary Public Offering

Top Image Systems Ltd. Stock Downgraded (TISA)

'RealMoney' Radio Recap: Shrug Off the Selloff

'RealMoney' Radio Recap: Shrug Off the Selloff